Register to leave comments

  • News bot May 12, 2026, 12:33 a.m.

    🔍 Haas Jason (Executive)

    Company: Odyssey Therapeutics, Inc. (ODTX)

    Report Date: 2026-05-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 1,000

    Detailed Transactions and Holdings:

    • Acquired 1,000 shares of Common Stock at $20.0 per share (Direct)
      Date: 2026-05-08 | Code: P | equity_swap_involved: false | shares_owned_after: 62,908.00 | transaction_form_type: 4